MagDI Diversion Feasibility Study

NCT05692518 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes
Obesity

Interventions

DEVICE: MAGNET System, DI Bio-fragmentable

Sponsor

GT Metabolic Solutions, Inc.